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Background: The prevalence of iron deficiency is increasing in the cystic fibrosis (CF) 
patients. The aim of this study was to determine the prevalence of iron deficiency ane-
mia and its correlation with pulmonary function in cystic fibrosis patients.
Materials and Methods: This descriptive-analytic study was conducted on the patients 
with cystic fibrosis who were referred to the Mofid Children Hospital, Tehran, Iran during 
2015-2016. Complete blood counting and iron indices were evaluated; furthermore, 
Pulmonary function test was performed in ≥ 5 years old patients to determine the forced 
expiratory volume in first second (FEV1), forced vital capacity (FVC), FEV1/FVC and 
forced expiratory flow (FEF25-75). The data were analyzed by SPSS software. Pear-
son correlation coefficient, t-test, Fisher’s exact test and χ2 were used for analyzing 
data. 
Results: Among 62 CF patients who presented to the hospital in the study period, 30 
patients were able to perform spirometry and included in the study. Spirometry findings 
were normal in 12 patients (40%) which 72% of them were female. There was a sta-
tistically significant correlation between the spirometric findings and the gender of the 
patients (P < 0.05); although, the correlation between the gender and iron indices was 
not significant (P > 0.05). Moreover, there was no statistically significant correlation 
between spirometric findings and iron indices (P > 0.05).
Conclusion: There was no significant correlation between the iron deficiency and the 
pulmonary function in cystic fibrosis patients.
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INTRODUCTION
Cystic fibrosis (CF) is an autosomal recessive disorder which 
is caused by the mutation in the cystic fibrosis transmembrane 
conductance regulator (CFTR) gene [1]. The defect of this gene 
caused some changes in the viscosity, volume, and concentra-
tion of salt in the secreted fluid of the body [2]. CF has some 
complications in all organs; although, 85% of the mortality is 
due to pulmonary disorders including chronic pulmonary dis-
ease and progressive chronic hypoxia [3, 4]. Although the dis-
ease is untreatable, but supportive cares improved life expec-
tancy in CF patients [5]. 
Iron deficiency anemia is common in CF patients which af-
fects 10-33% of patients [6-9]. Furthermore, CF patients with 
anemia have lover levels of pulmonary function in compare to 
non-anemic CF patients [10]. The pathophysiology of anemia 
in these patients is multifactorial; although, some mechanisms 
including chronic inflammation, blood loss from gastrointes-
tinal (GI) tract and, malnutrition may be responsible for ane-
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t-test, exact Fisher’s test and χ2 were used to determine the 
association of iron indices with the severity of pulmonary in-
volvement in cystic fibrosis patients. The level of P < 0.05 was 
considered significant.
Ethical Consideration
All patients were enrolled in this study after receiving a written 
consent. This study has been done after obtaining the permis-
sion of ethical committee of the Shahid Beheshti University 




Sixty-two CF patients who referred to the pulmonary and lung 
disease clinic of Mofid hospital during were entered in the 
study at the initial phase which 30 patients were eligible for 
spirometry evaluation. In terms of gender, 24 patients (39%) 
were female and 38 patients (61%) were male. The mean age of 
patients was 6 ± 5 years, with a range of 4 months to 20 years.
Lab Data
Laboratory values of iron indices, CBC and pulmonary func-
tion tests are presented in Table 1. In total, 4 patients (6.5%) 
had iron deficiency, 24 patients (38.7%) had ferritin deficiency 
and 10 patients (16.1%) had transferrin saturation deficiency; 
in addition, the serum iron level had a direct correlation with 
transferrin saturation (P < 0.001 and r = 0.899); Furthermore, 
a negative correlation was observed between the ferritin level 
and total iron binding capacity (P <0.001 and r = -0.490). In 
terms of CBC evaluation, 3 patients (7.8%) had RBC deficien-
cy, 7 patients (11.3%) and 13 patients (21.0%) had MCHC and 
MCH deficiency respectively. In addition, 15 patients (24.2%) 
had low MCV level, 12 patients (19.4%) had low HCT level 
and 16 patients (25.8%) had low hemoglobin (Table 2).
There were no statistically significant differences between the 
gender of patients and the serum iron level (P = 0.637), serum 
ferritin (P = 0.913), transferrin saturation (P = 0.1) and total 
iron binding capacity (P = 0.541). However, the relation be-
tween mean age of patients with serum iron deficiency (P < 
0.001) and serum ferritin (P = 0.013) was statistically signifi-
cant. 
Spirometry findings
A total of 30 patients were able to perform spirometry and the 
spirometric findings of patients summarized in Table 1. Spiro-
metric findings were normal in 11 patients (37%). In addition, 
four patients had obstructive pattern (13%); 2 patients had re-
strictive pattern (7%), and 13 patients (43%) had mix pattern in 
the spirometry evaluation. Furthermore, there was a statistical-
ly significant difference between the spirometry findings and 
the gender of the patients under study (P = 0.024). 
The level of iron indices by the distribution of spirometry find-
ings is presented in Table 3. There was no statistically signifi-
cant difference between the mean spirometry findings and the 
iron indices level in the patients under study.
mia in CF patients [11-13]. In addition, malabsorption, chronic 
inflammation, and hypoxia in CF patients can be related with 
the iron metabolism and the type of anemia [14]. However, in 
the anemia which caused by CF chronic inflammation is also 
important as iron deficiency and plays a critical role in the lack 
of response to iron therapy [15]. 
The present study was aimed to determine the prevalence of 
iron deficiency anemia and its effect on the pulmonary function 
in children with cystic.
MATERIALS and METHODS
Study Design
This descriptive-analytical study was aimed to determine the 
prevalence of the iron deficiency anemia and its correlation 
with the pulmonary function in cystic fibrosis patients who re-
ferred to pulmonary and lung disease clinic of Mofid hospital, 
Tehran, Iran during 2015-2016. 
Convenience sampling was used for patient selection and the 
sample size was considered to be approximately 60 CF pa-
tients, based on the power of 80% and the significant level of 
0.05 and the recent studies (10, 16). The inclusion criteria were 
the definitive diagnosis of cystic fibrosis according to diagnos-
tic criteria and 6 hours of fasting for measuring serum ferritin 
levels. In addition, patients who had the history of iron supple-
ments consumption were excluded from the study. 
Patient Assessment
The diagnosis of CF was confirmed by the result of a two-time 
measurement of sweating chlorine content and if the test result 
was above 60 meq/L, it was considered positive [17].  After 
that, complete blood count (CBC) and iron indices including 
serum iron, serum ferritin, transferrin saturation and total iron 
binding capacity were measured on a blood sample which was 
taken from the patients. The CBC was analyzed by Sysmex® 
hematology analyzer (xp-100, Singapore) and Iron indices 
were measured by Tokyo Boeki Biolis® 24i Premium device. 
Ferritin deficiency were considered below 30 μg/L in serum 
analysis [18]. In addition, CBC and iron counting values were 
adapted according to age and gender of the patient (19). Fur-
thermore, the transferrin saturation percentage was calculated 
according to Nelson’s book and values less than 16% were con-
sidered as deficiency [18].
Pulmonary evaluation was done if the patient had no symptoms 
of upper respiratory tract infection, acute sinusitis, and exacer-
bation of coughing in the last 2 weeks by the spirometry unit 
with Ganshorn® Spirometers (LF8.5K.SR1 edition, Germa-
ny). The exhale maneuvers test including FEV1, FVC, FEV1 / 
FVC and FEF25-75 ratio were done and values less than 80% 
were considered as a poor pulmonary function [20]. 
Data Analysis
All spirometry findings and lab tests were recorded in a ques-
tionnaire and entered to SPSS software. The data were an-
alyzed by SPSS software version 15. In this study, we used 
mean and standard deviation for analyzing quantitative vari-
ables; moreover, the frequency and the proportion were used 
for qualitative variables. The Pearson correlation coefficient, 
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Table 1. The results of CBC
Mean±SDVariables
71.1 ± 29.2Serum Iron (µg/dl)
278.6 ± 59.1Ferritin (ng/mL)
68.9 ± 75.0Transferrin Saturation (%)
25.3 ± 10.4TIBC (µg/dl)
8565.8 ± 4891.0White Blood Cell (n/µL)
4.8×106 ± 0.55×106Red Blood Cell (n/µL)
32.3 ± 1.8MCHC (gr/dl)
25.3 ± 2.8MCH (pg/cell)
78.1 ± 7.1MCV (µm3)
37.5 ± 4.7Hematocrit (%)
12.2 ± 1.7Hemoglobin (gr/dl)
323.1 ± 94.6Platelets (×103/µL)
13.3 ± 1.9RDW(%)
MCHC: mean corpuscular hemoglobin concentration; 
MCV: Mean Corpuscular Volume; MCH: Mean Corpuscular 
Hemoglobin; RDW: Red blood cell distribution width
Table 2. CBC deficiency related to anemia in CF patients










MCHC: mean corpuscular hemoglobin concentration; 
MCV: Mean Corpuscular Volume; MCH: Mean Corpuscular 
Hemoglobin
Table 3. The results of spirometry assessment
Mean±SDVariables
76.9 ± 33.6FEV1 (%)
78.7 ± 29.9FVC (%)
83.5 ± 13.0FEV1/FVC (%)
57.4 ± 42.5FEF25-75 (%)
FVC: Forced Vital Capacity; FEV: Forced Expiratory Vol-
ume; FEF: Forced Expiratory Flow
Correlation of iron indices and pulmonary function
The distribution of spirometry findings in patients with CF in 
terms of iron indices level are presented in Table 4.
Seventeen percent of patients with iron deficiency had poor 
pulmonary function. There was no statistically significant differ-
ence between the spirometry findings and the serum iron level 
in the patients (P = 0.632); in addition, 44% percent of patients 
with serum ferritin deficiency had poor pulmonary function. 
There was no statistically significant difference between the 
spirometry findings and the serum ferritin levels in the patients 
(P = 0.284); furthermore, 28% of patients with low transferrin 
saturation had poor lung function. There was no statistically sig-
nificant difference between spirometry findings and transferrin 
saturation values in patients under study (P=0.358).
The findings showed that in 30 patients with spirometric find-
ings, 20 patients had evidence of iron deficiency which 12 of 
them (60%) had poor lung function. There was no statistically 
significant difference between poor lung function and evidence 
of iron deficiency (P = 0.1).
DISCUSSION
In this study, 30 patients among 62 CF patients were able to per-
form spirometry. Poor lung function was more prevalent in fe-
male patients. Also, 17% of patients with deficit of iron, 44% of 
patients with ferritin deficiency, 28% of patients with low trans-
ferrin saturation, 17% of patients with low iron binding capacity 
had poor lung function. There was no statistically significant re-
lationship between spirometric findings and serum level of iron 
indices in patients.
In O’Connor TM et al study, hemoglobin and oxygen saturation 
indices were studied in 17 healthy individuals and 15 adults with 
cystic fibrosis. There was no statistically significant difference 
between hemoglobin and hematocrit values in patients with cys-
tic fibrosis and control group which is in line with our study 
results [16]. In addition, Serum iron levels, transferrin and total 
iron binding capacity were significantly lower in patients with 
cystic fibrosis in the study; however, there was no significant 
difference in serum ferritin, iron saturation, serum erythropoi-
etin, and red blood cell volume which was same with the result 
of our study [16]. 
Hansen et al. Reviewed 60 patients with 19-20 years of age with 
cystic fibrosis. The mean of hemoglobin was 140±14.1 g/L, and 
normal MCV was reported in 91.7% of cases. The serum iron 
level in 60% of subjects was less than 12 μmol/L, and TIBC 
values were normal. Serum concentrations of ferritin in 21.7% 
of subjects were less than 23 μg/L. Transfusion saturation was 
less than 16% indicating iron deficiency, which was reported 
in 41.7% of patients [21]. The results of this study are differ-
ent from our study, perhaps the reason for this difference in the 
statistic between the two studies is the average age of patients. 
This point indicates that more studies are needed in different age 
groups for this study.
In the study of Uijterschout L et al. on 53 children under the age 
of 16 with CF, iron deficiency was defined as ferritin less than 
12 μg/L in children less than 5 years of age and less than 15 
μg/L in children aged 5 years and above. The results showed that 
thirty-two children (60.4%) had iron deficiency at least 1 year 
and ten children (18.9%) had anemia at least 1 year. Ferritin had 
a positive correlation with the age of the patients like the results 
of the current study [22]. 
In the study of von Drygalski et al [10], there was no statistical-
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